BISON, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 3.330
AS - Asia 1.831
EU - Europa 948
SA - Sud America 310
AF - Africa 289
Continente sconosciuto - Info sul continente non disponibili 65
OC - Oceania 20
Totale 6.793
Nazione #
US - Stati Uniti d'America 3.137
SG - Singapore 558
CN - Cina 344
IT - Italia 298
VN - Vietnam 280
BR - Brasile 188
HK - Hong Kong 143
BD - Bangladesh 127
DE - Germania 99
FI - Finlandia 79
CA - Canada 48
IN - India 47
FR - Francia 46
GB - Regno Unito 44
NL - Olanda 43
AR - Argentina 38
SE - Svezia 36
PL - Polonia 33
RU - Federazione Russa 32
TR - Turchia 27
IQ - Iraq 26
CI - Costa d'Avorio 25
JP - Giappone 24
SA - Arabia Saudita 22
ID - Indonesia 20
ES - Italia 19
CO - Colombia 18
JM - Giamaica 16
PK - Pakistan 16
UA - Ucraina 15
AT - Austria 14
HR - Croazia 14
ZA - Sudafrica 14
AZ - Azerbaigian 13
BE - Belgio 13
IE - Irlanda 13
KR - Corea 13
MA - Marocco 13
VE - Venezuela 13
EC - Ecuador 12
HN - Honduras 12
MX - Messico 12
MY - Malesia 12
CR - Costa Rica 11
LB - Libano 11
RO - Romania 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
CL - Cile 10
CZ - Repubblica Ceca 10
EG - Egitto 10
ET - Etiopia 10
GN - Guinea 10
NO - Norvegia 10
NP - Nepal 10
PH - Filippine 10
TT - Trinidad e Tobago 10
TW - Taiwan 10
XK - ???statistics.table.value.countryCode.XK??? 10
ZW - Zimbabwe 10
CM - Camerun 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
GM - Gambi 9
KG - Kirghizistan 9
KZ - Kazakistan 9
MR - Mauritania 9
PE - Perù 9
PT - Portogallo 9
SN - Senegal 9
TZ - Tanzania 9
BJ - Benin 8
BY - Bielorussia 8
GH - Ghana 8
LT - Lituania 8
MD - Moldavia 8
NG - Nigeria 8
PA - Panama 8
PY - Paraguay 8
TJ - Tagikistan 8
TN - Tunisia 8
VC - Saint Vincent e Grenadine 8
YT - Mayotte 8
GP - Guadalupe 7
IR - Iran 7
KE - Kenya 7
MW - Malawi 7
NI - Nicaragua 7
PR - Porto Rico 7
RW - Ruanda 7
UY - Uruguay 7
AD - Andorra 6
BF - Burkina Faso 6
BG - Bulgaria 6
CU - Cuba 6
DJ - Gibuti 6
DK - Danimarca 6
GA - Gabon 6
GR - Grecia 6
Totale 6.499
Città #
Ashburn 474
San Jose 407
Singapore 345
Fairfield 299
Chandler 192
Woodbridge 182
Houston 136
Hong Kong 122
Cambridge 119
Seattle 103
Ann Arbor 95
Beijing 88
Wilmington 85
Ho Chi Minh City 83
Hanoi 73
Santa Clara 72
Council Bluffs 63
New York 53
Los Angeles 52
Munich 40
Boardman 37
Helsinki 37
Milan 32
San Diego 28
Buffalo 27
Princeton 27
São Paulo 27
Lauterbourg 26
Abidjan 25
Des Moines 25
Frankfurt am Main 25
Medford 22
Orem 22
Padova 22
Chicago 20
Turku 19
Bytom 18
Tokyo 18
Phoenix 16
Jacksonville 14
Nanjing 14
Rome 14
Hefei 13
Baku 12
Haiphong 12
Roxbury 12
Toronto 12
Warsaw 12
Chennai 11
Dublin 11
Montreal 11
Redondo Beach 11
Baghdad 10
Conakry 10
Da Nang 10
Harare 10
Kingston 10
Naples 10
Zagreb 10
Dakar 9
Nuremberg 9
Pristina 9
Tashkent 9
Bishkek 8
Biên Hòa 8
Brooklyn 8
Dallas 8
Dar es Salaam 8
Hebei 8
Johannesburg 8
Kingstown 8
London 8
Nouakchott 8
Vienna 8
Brussels 7
Dushanbe 7
Guangzhou 7
Istanbul 7
Kigali 7
Las Vegas 7
Managua 7
Minsk 7
Mumbai 7
Nanchang 7
Padua 7
Panama City 7
Riyadh 7
San José 7
Accra 6
Addis Ababa 6
Andorra la Vella 6
Athens 6
Atlanta 6
Bamako 6
Bologna 6
Boston 6
Buenos Aires 6
Can Tho 6
Caracas 6
Dearborn 6
Totale 4.079
Nome #
Laboratory testing for antiphospholipid syndrome 290
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies 290
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 266
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns 264
APS - Diagnostics and challenges for the future 258
The Paradox of the Lupus Anticoagulant: History and Perspectives 258
Laboratory Diagnostics of Antiphospholipid Syndrome 252
Diagnosis and therapy of antiphospholipid syndrome 251
Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study 248
A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis 246
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 241
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 233
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk 230
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome. 230
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant 227
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 220
Confirmation of the initial antiphospholipid antibody positivity depends on antiphospholipid antibody profile 218
Antiphospholipid syndrome: critical analysis of the diagnostic path 215
Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity? 213
Cellular Immunology of Myocarditis: Lights and Shades—A Literature Review 210
The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review 200
Interpretation of laboratory data and need for reference laboratories. 198
Correct laboratory approach to APS diagnosis and monitoring 198
The role of platelets in antiphospholipid syndrome 198
Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature 196
Serum Anti-Heart and Anti-Intercalated Disk Autoantibodies: Novel Autoimmune Markers in Cardiac Sarcoidosis 177
Secondary prevention in thrombotic antiphospholipid syndrome. 175
Prevalence and Correlates of Anti-DSG2 Antibodies in Arrhythmogenic Right Ventricular Cardiomyopathy and Myocarditis: Immunological Insights from a Multicenter Study 167
Standardization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability 144
Assessment of thrombophilia in patients with lupus anticoagulant 141
Cardiac troponin interferents in diagnosis and clinical management of myocarditis: a single center experience. 99
Plasma prothrombin antigenic levels across thrombotic and hemorrhagic phenotypes in triple-positive antiphospholipid patients with antiprothrombin antibodies 18
Biopsy-proven myocarditis: peripheral immunophenotypes correlate with histology, etiology, immunosuppressive therapy 13
Expanding the Therapeutic Landscape of Pericarditis: A Systematic Review of the Use of Conventional Immunosuppressants 9
Totale 6.793
Categoria #
all - tutte 19.611
article - articoli 19.611
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 0 0 51 25 8 22 19 50 11 13 32 88
2022/2023354 61 40 7 50 43 48 4 27 35 8 25 6
2023/2024189 4 18 18 27 12 30 19 20 6 9 9 17
2024/2025847 3 56 44 33 78 17 65 71 79 44 150 207
2025/20263.582 182 212 402 535 324 152 556 254 442 173 177 173
2026/2027334 144 187 3 0 0 0 0 0 0 0 0 0
Totale 6.793